n-hydroxythalidomide has been researched along with thalidomide in 8 studies
| Studies (n-hydroxythalidomide) | Trials (n-hydroxythalidomide) | Recent Studies (post-2010) (n-hydroxythalidomide) | Studies (thalidomide) | Trials (thalidomide) | Recent Studies (post-2010) (thalidomide) |
|---|---|---|---|---|---|
| 8 | 0 | 2 | 9,789 | 1,385 | 4,342 |
| Protein | Taxonomy | n-hydroxythalidomide (IC50) | thalidomide (IC50) |
|---|---|---|---|
| Cereblon isoform 4 | Magnetospirillum gryphiswaldense | 7.8 | |
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 0.37 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 0.5 | |
| DNA damage-binding protein 1 | Homo sapiens (human) | 1.38 | |
| Protein cereblon | Homo sapiens (human) | 1.38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, Y; Katayama, R; Miyachi, H; Naito, M; Noguchi, T | 1 |
| Hashimoto, Y; Makishima, M; Miyachi, H; Nakagawa, A; Uno, S | 1 |
| Blaschke, G; Hess, HR; Lüpke, NP | 1 |
| Chuong, PH; Claude, JR; Galons, H; Huynh-Thien, D; Righenzi, S; Voisin, J; Warnet, JM; Zhu, J | 1 |
| Blaschke, G; Chankvetadze, B; Meyring, M | 2 |
| Baran, PS; Che, G; Eastgate, MD; Edwards, JT; Liu, Z; Malins, LR; Merchant, RR; Qin, T; Shaw, SA; Shen, Z; Smith, JM | 1 |
| Fu, H; Gao, H; Huang, J; Lan, H; McGinty, S; Wang, G; Wang, Y; Wang, Z; Yin, T; Zhang, X | 1 |
8 other study(ies) available for n-hydroxythalidomide and thalidomide
| Article | Year |
|---|---|
Cell differentiation inducers derived from thalidomide.
Topics: Antineoplastic Agents; Cell Differentiation; Drug Screening Assays, Antitumor; Flow Cytometry; HL-60 Cells; Humans; Indoles; Isoindoles; Leukemia; Lipopolysaccharide Receptors; Structure-Activity Relationship; Thalidomide | 2005 |
Progesterone receptor antagonists with a 3-phenylquinazoline-2,4-dione/2-phenylisoquinoline-1,3-dione skeleton.
Topics: Alkaline Phosphatase; Animals; Cell Line, Tumor; CHO Cells; Cricetinae; Cricetulus; Genes, Reporter; Humans; Inhibitory Concentration 50; Quinazolines; Quinolines; Receptors, Progesterone; Structure-Activity Relationship | 2008 |
[Synthesis and teratogenic action of n-hydroxythalidomide].
Topics: Animals; Chemical Phenomena; Chemistry; Chick Embryo; Teratogens; Thalidomide | 1989 |
In vitro and in vivo immunosuppressive potential of thalidomide and its derivative, N-hydroxythalidomide, alone and in combination with cyclosporin A.
Topics: Animals; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Graft vs Host Reaction; Immunosuppressive Agents; Lymphocyte Activation; Mice; T-Lymphocytes; Thalidomide | 1997 |
Enantioseparation of thalidomide and its hydroxylated metabolites using capillary electrophoresis with various cyclodextrins and their combinations as chiral buffer additives.
Topics: Acrylic Resins; Buffers; Cyclodextrins; Electrophoresis, Capillary; Humans; Molecular Structure; Silicon Dioxide; Thalidomide | 1999 |
Simultaneous separation and enantioseparation of thalidomide and its hydroxylated metabolites using high-performance liquid chromatography in common-size columns, capillary liquid chromatography and nonaqueous capillary electrochromatography.
Topics: Chromatography, High Pressure Liquid; Electrophoresis, Capillary; Hydroxylation; Stereoisomerism; Thalidomide | 2000 |
Decarboxylative Alkynylation.
Topics: Alkynes; Decarboxylation; Esters; Molecular Structure; Nickel; Phthalimides; Thalidomide | 2017 |
Covalent immobilization of biomolecules on stent materials through mussel adhesive protein coating to form biofunctional films.
Topics: Carbodiimides; Cell Proliferation; Cell Survival; Coated Materials, Biocompatible; Dimethylamines; Endothelial Cells; Humans; Microscopy, Electron, Scanning; Proteins; Stents; Thalidomide | 2020 |